Concepedia

Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study

Mathurin Fuméry, Claire Dupont, Delphine Ley, Guillaume Savoye, Valérie Bertrand, Nathalie Guillon, Pauline Wils, Corinne Gower‐Rousseau, Hélène Sarter, Dominique Turck,

Digestive and Liver Disease · 2023 · 17 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

Pediatric modification of the Montreal classification for inflammatory bowel disease

Arie Levine, Anne M. Griffiths, James Markowitz et al. · Inflammatory Bowel Diseases · 2010 · 1.5K citations · Full text

, , +14

Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan et al. · Gastroenterology · 2006 · 870 citations · Full text

, , +12

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

, , +17

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

Christopher M. Booth, Ian F. Tannock · British Journal of Cancer · 2014 · 470 citations · Full text

, , +13